1. Home
  2. CLDX vs ENR Comparison

CLDX vs ENR Comparison

Compare CLDX & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • ENR
  • Stock Information
  • Founded
  • CLDX N/A
  • ENR 2015
  • Country
  • CLDX United States
  • ENR United States
  • Employees
  • CLDX N/A
  • ENR N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ENR Industrial Machinery/Components
  • Sector
  • CLDX Health Care
  • ENR Miscellaneous
  • Exchange
  • CLDX Nasdaq
  • ENR Nasdaq
  • Market Cap
  • CLDX 1.6B
  • ENR 1.8B
  • IPO Year
  • CLDX 2008
  • ENR N/A
  • Fundamental
  • Price
  • CLDX $26.22
  • ENR $24.69
  • Analyst Decision
  • CLDX Strong Buy
  • ENR Hold
  • Analyst Count
  • CLDX 8
  • ENR 7
  • Target Price
  • CLDX $46.13
  • ENR $31.43
  • AVG Volume (30 Days)
  • CLDX 1.1M
  • ENR 909.0K
  • Earning Date
  • CLDX 11-05-2025
  • ENR 11-18-2025
  • Dividend Yield
  • CLDX N/A
  • ENR 4.85%
  • EPS Growth
  • CLDX N/A
  • ENR 2300.45
  • EPS
  • CLDX N/A
  • ENR 3.41
  • Revenue
  • CLDX $5,790,000.00
  • ENR $2,925,600,000.00
  • Revenue This Year
  • CLDX N/A
  • ENR $3.12
  • Revenue Next Year
  • CLDX N/A
  • ENR $2.92
  • P/E Ratio
  • CLDX N/A
  • ENR $7.24
  • Revenue Growth
  • CLDX N/A
  • ENR 1.15
  • 52 Week Low
  • CLDX $14.40
  • ENR $19.70
  • 52 Week High
  • CLDX $31.66
  • ENR $39.52
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 60.30
  • ENR 37.32
  • Support Level
  • CLDX $24.49
  • ENR $23.92
  • Resistance Level
  • CLDX $26.90
  • ENR $25.31
  • Average True Range (ATR)
  • CLDX 1.00
  • ENR 0.84
  • MACD
  • CLDX 0.07
  • ENR -0.36
  • Stochastic Oscillator
  • CLDX 79.27
  • ENR 13.67

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About ENR Energizer Holdings Inc.

Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.

Share on Social Networks: